ALLOGENIC BMT IN CHILDREN - DIFFERENTIAL LYMPHOCYTE SUBSET RECONSTITUTION ACCORDING TO THE OCCURRENCE OF ACUTE GVHD

被引:7
作者
GARIN, L
RIGAL, D
SOUILLET, G
NEMOZ, C
BERNAUD, J
MERIEUX, Y
PHILLIPPE, N
机构
[1] HOP DEBROUSSE,SERV HEMATOL PEDIAT,F-69322 LYON 05,FRANCE
[2] LAB INFORMAT MED,F-69424 LYON 03,FRANCE
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1995年 / 77卷 / 02期
关键词
D O I
10.1006/clin.1995.1137
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To acquire some biological markers associated with the occurrence of acute graft-versus-host disease (aGVHD) after allogeneic bone marrow transplant (BMT) in children, we have studied the lymphocyte subset reconstitution and the percentage of peripheral blood mononuclear cells bearing HLA-DR and HLA-DQ class II molecules, This study included 37 allogeneic BMT: either with (n = 17) or without (n = 20) aGVHD. Within 2 months after transplantation, we observed that patients with aGVHD had a unique mononuclear cell profile characterized by (i) a significant increase in the percentages of CD8(bright+)CD28(-) T cells (P = 0.05) and CD3(+) T cells (P = 0.001), (ii) an important decrease in the percentage of CD56(+) cells (P = 0.0001), and (iii) a decrease in the percentages of HLA-DQ(+) and HLA-DR(+) monocytes (P = 0.001), and HLA-DQ(+) T lymphocytes (P = 0.0001), in comparison with patients without aGVHD. Moreover, statistical studies indicate that there was a positive correlation between CD8(bright)CCD28(-) and CD3(+) T cells, whereas CD3(+) T cells were negatively correlated to CD56(+) cells. We did not find any statistical correlation between the percentages of HLA-DQ(+) or HLA-DR(+) cells and the percentages of these lymphocyte subsets, Therefore, in this study done in children, we suggest that patients with (i) less than 20% of DQ(+) monocytes, (ii) less than 25% of CD56(+) lymphocytes, and (iii) an enhanced percentage of CD8(bright)CCD28(-) T cells are strongly associated with aGVHD. Unfortunately, these biological markers of aCVHD may not precede the clinical manifestations of the disease. (C) 1995 Academic Press, Inc.
引用
收藏
页码:139 / 148
页数:10
相关论文
共 24 条
[1]  
ATKINSON K, 1982, BLOOD, V59, P1292
[2]  
AZUMA M, 1993, J IMMUNOL, V150, P1147
[3]  
CHAMPLIN R, 1990, BLOOD, V73, P418
[4]  
FERRARA JLM, 1991, NEW ENGL J MED, V324, P667
[5]  
GARIN L, 1994, CLIN EXP IMMUNOL, V96, P344
[6]   CHARACTERIZATION OF CIRCULATING SUPPRESSOR LYMPHOCYTES-T IN BONE-MARROW TRANSPLANT RECIPIENTS [J].
GEBEL, HM ;
KAIZER, H ;
LANDAY, AL .
TRANSPLANTATION, 1987, 43 (02) :258-263
[7]  
HESS AD, 1992, BONE MARROW TRANSPL, V10, P16
[8]  
JUNE CH, 1990, IMMUNOL TODAY, V6, P211
[9]  
KEEVER CA, 1989, BLOOD, V73, P1340
[10]   PHENOTYPICAL AND FUNCTIONAL-STUDIES ON A SUBTYPE OF SUPPRESSOR CELLS (CD8+/CD11+) IN PATIENTS AFTER BONE-MARROW TRANSPLANTATION [J].
KLINGEMANN, HG ;
LUM, LG ;
STORB, R .
TRANSPLANTATION, 1987, 44 (03) :381-386